The identifier is most commonly associated with a highly cited scientific review regarding microalgae-based wastewater treatment , published in the journal Bioresource Technology in 2019.
: It serves as the JapicCTI identifier ( 121934 ) for a study funded by Chugai Pharmaceutical. This trial reviewed the effectiveness of emicizumab , a subcutaneous treatment that significantly decreased bleeding rates in hemophilia A patients. 121934
While the wastewater review is the most prominent "121934" in academic searches, the number also appears in these niche contexts: The identifier is most commonly associated with a
Microalgae-based wastewater treatment for nutrients recovery 121934